Tennant Company - Q3 2026 Earnings Release - TENNANT CO

Financial Performance:

• Net sales reached a record $322.3 million in Q3 2026, up 6.2% year-over-year (YOY) with 5.7% organic growth driven by 4.1% volume and 1.6% price.
• Adjusted EBITDA was $48.8 million (15.1% margin), including $6.1 million in one-time tariff refunds; excluding refunds, margin improved 235 bps sequentially to ~13.2%.
• GAAP net income increased to $19.5 million ($1.12/share) from $14.9 million ($0.80/share) YOY, boosted by lower ERP costs and absence of prior legal contingencies.
• Normalized gross margin was 40.4% (up 90 bps sequentially), though still below prior year levels due to freight/material inflation and production inefficiencies.
• Operating cash flow improved to $11.9 million (up from $5 million in Q2), though still down YOY due to higher working capital needs.
• Cash position ended at $75.3 million with $289.4 million in unused revolver capacity and net leverage of 2.0x EBITDA.

Guidance and Future Outlook:

• Reaffirmed full-year 2026 guidance: Net sales $1.27B–$1.31B (5.5%–9% reported growth), Adjusted EBITDA $155M–$170M (12.2%–13% margin), and Adjusted EPS $3.80–$4.45.
• Q4 implied outlook suggests net sales of ~$346 million and Adjusted EBITDA of ~$49 million (14% margin), supported by backlog conversion and EMEA recovery.
• Robotics revenue guidance for 2026 set at $130M–$145M, maintaining the long-term target of $250M by 2028.
• 2027 outlook to be provided with Q4 2026 results; near-term priorities include converting order momentum, capturing ERP efficiencies, and scaling robotics.

Business Segments and Product Lines:

• Robotics segment accelerated with $37 million in Q3 revenue (up 71% YOY); YTD robotics revenue ($95.3M) already exceeds full-year 2025 total.
• Launched X2 Rover and X16 Sweep (X-series) with robust order books; P1VAC (Performance Series) launched as first autonomous vacuum, targeting value-conscious markets via distribution.
• Strategic partnership with BrainCorp extended for 3 years to develop next-gen floor care; plan to introduce 10 new products within 24 months.
• Americas showed strong performance with 8.1% organic sales growth; APAC saw a 4.8% decline in sales due to distributor overstock in China/Australia, though orders grew 7%.
• EMEA pricing strategies took hold with positive price realization, though orders softened by 9% in the quarter.

Market and Competitive Landscape:

• Order demand remains robust globally, with back-to-back quarterly order growth for 2026; Q3 orders grew 9.5%, led by North America (18%).
• Premium market strategy focuses on X-series with AI/autonomy via BrainCorp, while the new P-series targets accessible price points to expand Total Addressable Market (TAM).
• Market trends show elevated distributor inventories in Asia-Pacific slowing deal conversion; demand indicators in Americas remain healthy with an expanding opportunity funnel.
• Competition addressed through a dual-product strategy: premium autonomous solutions for complex applications and value-oriented models for routine cleaning via distribution.

Risks and Challenges:

• Margin pressure persists due to inflationary freight and material costs linked to the Middle East conflict, alongside parts availability constraints causing under-absorption.
• ERP system inefficiencies, while significantly reduced to ~$2M in Q3 from $10M in H1, continue to impact production and invoicing, with residual effects expected to taper in Q4.
• EMEA order momentum softened in August, requiring recovery efforts; APAC performance lags expectations due to regional economic softness.
• Part shortages, while easing, are not fully resolved and could impact the robotics production ramp and Q4 delivery schedules.

Management Commentary and Tone:

• Tone was confident and forward-looking, emphasizing the transition from ERP "recovery" to "optimization" and the acceleration of the robotics business.
• Management expressed strong confidence in Q4 performance driven by backlog visibility and seasonal trends, despite acknowledging macro headwinds.
• Key strategic shift highlighted was the decision to delay EMEA ERP deployment to mitigate risk and focus resources on North America optimization.
• Board approved a 5% dividend increase to $0.325/share, signaling confidence in cash flow generation and capital return capabilities.

Analyst Questions and Answers:

• Gross Margins: Clarified that $6.1M in tariff refunds contributed ~190 bps; normalized margin beat expectations primarily due to price realization.
• ERP Impact: Confirmed ERP-related gross margin drag fell to ~$2M in Q3 (down from $10M H1) with expectations to drop further in Q4; challenges are now residual (warehouse management, invoicing, data) rather than systemic.
• Component Availability: Parts shortages are easing across the board, including for robotics components (sensing/compute), with extended line-of-sight to meet production demand.
• New Products (P1VAC): Explained the vacuum launch addresses a specific value-market gap via a contract manufacturing model to ensure profitability and speed; shipping begins in Q6 (calendar year) with pre-orders already taken.
• S&A Expenses: Attributed lower-than-expected S&A spending partly to LTI accrual adjustments, though long-term IT support costs for ERP remain.

Other Key Points:

• Capital allocation remains balanced: $6.7M in capex, $5.2M in dividends returned in the quarter, totaling $76.6M in capital returns for the year.
• Inventory increased to $213.2 million (+$15M YoY) to support robotics production ramp and buffer against supply chain volatility.
• Accounts Receivable rose to $291.7 million due to invoicing optimization post-ERP; collection timing is a priority for Q4.
• The company is reassessing its domestic commercial strategy in China to align with current market conditions and distributor inventory levels.